The global market for cloud computing in cell biology, genomics, and drug development is expected to grow significantly, from $6.2 billion in 2024 to $15.6 billion by 2030, marking a compound annual growth rate (CAGR) of 16.7%. This growth, detailed in a report by BCC Research, is driven by the explosion of biological data and the need for scalable computational resources, particularly in North America, which holds a 44.7% market share. Key advancements include the integration of AI and machine learning into drug discovery processes and the emergence of cloud-native bioinformatics platforms, making enterprise-grade capabilities accessible to smaller firms without heavy IT investments. As the industry shifts from on-premises to cloud-native solutions, companies that embrace this transition, particularly those with AI integration and regulatory compliance, are likely to thrive.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.globenewswire.com/news-release/2026/04/01/3266926/0/en/Cloud-Computing-in-Cell-Biology-Genomics-and-Drug-Development-to-Reach-15-6-Billion-by-2030-as-Biological-Data-Explosion-Drives-Demand.html
